| 1 | Spatial proteomic landscape of primary and relapsed hepatocellular carcinoma reveals immune escape characteristics in early relapse | 10.6 | 15 | Citations (PDF) |
| 2 | A Novel Coacervate Embolic Agent for Tumor Chemoembolization | 8.8 | 15 | Citations (PDF) |
| 3 | Dual‐Targeted Engineered Bacterial Outer Membrane Vesicles for Hepatocellular Carcinoma Immunotherapy | 17.0 | 8 | Citations (PDF) |
| 4 | SARS-CoV-2 causes a significant stress response mediated by small RNAs in the blood of COVID-19 patients | 5.6 | 21 | Citations (PDF) |
| 5 | Generation of three lines from multiorgan venous and lymphatic defect syndrome patients | 0.6 | 0 | Citations (PDF) |
| 6 | Loss-of-function Mutations K11E or E271K Lead to Novel Tumor Suppression, Implicate Nucleolar Helicase DDX24 Oncogenicity | 2.9 | 3 | Citations (PDF) |
| 7 | Efficacy of Near-Infrared Fluorescence-Guided Hepatectomy for the Detection of Colorectal Liver Metastases: A Randomized Controlled Trial | 0.7 | 35 | Citations (PDF) |
| 8 | Evaluation of Spike Protein Epitopes by Assessing the Dynamics of Humoral Immune Responses in Moderate COVID-19 | 5.1 | 6 | Citations (PDF) |
| 9 | SARS‐CoV‐2 spike spurs intestinal inflammation via VEGF production in enterocytes | 7.2 | 31 | Citations (PDF) |
| 10 | Application of Dynamic <sup>18</sup>F-FDG PET/CT for Distinguishing Intrapulmonary Metastases from Synchronous Multiple Primary Lung Cancer | 2.2 | 10 | Citations (PDF) |
| 11 | RNA Helicase DDX24 Stabilizes LAMB1 to Promote Hepatocellular Carcinoma Progression | 0.6 | 26 | Citations (PDF) |
| 12 | A Positron Emission Tomography Tracer Targeting the S2 Subunit of SARS-CoV-2 in Extrapulmonary Infections | 4.3 | 5 | Citations (PDF) |
| 13 | A proposal for clinical trials of COVID-19 treatment using homo-harringtonine | 9.8 | 11 | Citations (PDF) |
| 14 | Systematic evaluation of IgG responses to SARS-CoV-2 spike protein-derived peptides for monitoring COVID-19 patients | 15.6 | 49 | Citations (PDF) |
| 15 | Glycyrrhizic Acid Nanoparticles as Antiviral and Anti-inflammatory Agents for COVID-19 Treatment | 8.0 | 124 | Citations (PDF) |
| 16 | Near-infrared fluorescence-guided resection of micrometastases derived from esophageal squamous cell carcinoma using a c-Met-targeted probe in a preclinical xenograft model | 11.1 | 22 | Citations (PDF) |
| 17 | Predictors of fatal outcomes among hospitalized COVID‐19 patients with pre‐existing hypertension in China | 2.2 | 9 | Citations (PDF) |
| 18 | Cooperation of ATF4 and CTCF promotes adipogenesis through transcriptional regulation | 5.0 | 24 | Citations (PDF) |
| 19 | A SARS-CoV-2 antibody curbs viral nucleocapsid protein-induced complement hyperactivation | 13.9 | 87 | Citations (PDF) |
| 20 | Macrophage biomimetic nanocarriers for anti-inflammation and targeted antiviral treatment in COVID-19 | 11.6 | 82 | Citations (PDF) |
| 21 | A predictive score for progression of COVID-19 in hospitalized persons: a cohort study | 4.3 | 10 | Citations (PDF) |
| 22 | B cell heterogeneity, plasticity, and functional diversity in cancer microenvironments | 6.7 | 36 | Citations (PDF) |
| 23 | Altered oral and gut microbiota and its association with SARS-CoV-2 viral load in COVID-19 patients during hospitalization | 8.1 | 177 | Citations (PDF) |
| 24 | Quantitative immunohistochemistry (IHC) analysis of biomarker combinations for human esophageal squamous cell carcinoma | 1.8 | 9 | Citations (PDF) |
| 25 | Preclinical Evaluation of [<sup>64</sup>Cu]NOTA-CP01 as a PET Imaging Agent for Metastatic Esophageal Squamous Cell Carcinoma | 4.3 | 13 | Citations (PDF) |
| 26 | A deep learning-based radiomic nomogram for prognosis and treatment decision in advanced nasopharyngeal carcinoma: A multicentre study | 9.9 | 117 | Citations (PDF) |
| 27 | Near-infrared fluorescence imaging-guided lymphatic mapping in thoracic esophageal cancer surgery | 2.4 | 18 | Citations (PDF) |
| 28 | Bi/Se-Based Nanotherapeutics Sensitize CT Image-Guided Stereotactic Body Radiotherapy through Reprogramming the Microenvironment of Hepatocellular Carcinoma | 8.0 | 35 | Citations (PDF) |
| 29 | Fecal multi-omics analysis reveals diverse molecular alterations of gut ecosystem in COVID-19 patients | 5.8 | 41 | Citations (PDF) |
| 30 | The Role of Pretreatment 18F-FDG PET/CT for Early Prediction of Neoadjuvant Chemotherapy Response in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma | 4.5 | 8 | Citations (PDF) |
| 31 | A nanodrug incorporating siRNA PD-L1 and Birinapant for enhancing tumor immunotherapy | 5.7 | 11 | Citations (PDF) |
| 32 | Molecular Imaging of Collagen Destruction of the Spine | 15.3 | 27 | Citations (PDF) |
| 33 | Arsenite-loaded albumin nanoparticles for targeted synergistic chemo-photothermal therapy of HCC | 5.7 | 19 | Citations (PDF) |
| 34 | Nanovesicles derived from bispecific CAR-T cells targeting the spike protein of SARS-CoV-2 for treating COVID-19 | 11.6 | 32 | Citations (PDF) |
| 35 | TREM-2 is a sensor and activator of T cell response in SARS-CoV-2 infection | 11.0 | 41 | Citations (PDF) |
| 36 | SRXN1 stimulates hepatocellular carcinoma tumorigenesis and metastasis through modulating ROS/p65/BTG2 signalling | 4.1 | 42 | Citations (PDF) |
| 37 | Differential Diagnosis of COVID-19 Pneumonia in Cancer Patients Received Radiotherapy | 2.9 | 7 | Citations (PDF) |
| 38 | Histone deacetylase inhibitors promote epithelial-mesenchymal transition in Hepatocellular Carcinoma <i>via</i> AMPK-FOXO1-ULK1 signaling axis-mediated autophagy | 11.5 | 37 | Citations (PDF) |
| 39 | Longitudinal hematologic and immunologic variations associated with the progression of COVID-19 patients in China | 6.2 | 321 | Citations (PDF) |
| 40 | Targeted Theranostics for Tuberculosis: A Rifampicin-Loaded Aggregation-Induced Emission Carrier for Granulomas Tracking and Anti-Infection | 15.3 | 57 | Citations (PDF) |
| 41 | Successful use of methylprednisolone for treating severe COVID-19 | 6.2 | 67 | Citations (PDF) |
| 42 | Preliminary evidence from a multicenter prospective observational study of the safety and efficacy of chloroquine for the treatment of COVID-19 | 9.8 | 90 | Citations (PDF) |
| 43 | Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infection | 21.2 | 810 | Citations (PDF) |
| 44 | Treating COVID-19 with Chloroquine | 3.6 | 228 | Citations (PDF) |
| 45 | Evidence for Gastrointestinal Infection of SARS-CoV-2 | 1.0 | 2,404 | Citations (PDF) |
| 46 | Impact of coronavirus disease 2019 on pulmonary function in early convalescence phase | 4.5 | 475 | Citations (PDF) |
| 47 | Chest CT Findings in Coronavirus Disease-19 (COVID-19): Relationship to Duration of Infection | 8.9 | 2,199 | Citations (PDF) |
| 48 | Clinical Characteristics of Coronavirus Disease 2019 in China | 43.7 | 24,519 | Citations (PDF) |
| 49 | CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV) | 8.9 | 2,259 | Citations (PDF) |
| 50 | A new method of near-infrared fluorescence image-guided hepatectomy for patients with hepatolithiasis: a randomized controlled trial | 2.4 | 28 | Citations (PDF) |
| 51 | Molecular Probe Crossing Blood–Brain Barrier for Bimodal Imaging–Guided Photothermal/Photodynamic Therapies of Intracranial Glioblastoma | 17.0 | 55 | Citations (PDF) |
| 52 | Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sites | 12.8 | 620 | Citations (PDF) |
| 53 | Risk Factors of Fatal Outcome in Hospitalized Subjects With Coronavirus Disease 2019 From a Nationwide Analysis in China | 1.1 | 540 | Citations (PDF) |
| 54 | Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis | 12.1 | 2,796 | Citations (PDF) |
| 55 | Clinical characteristics and outcomes of hospitalised patients with COVID-19 treated in Hubei (epicentre) and outside Hubei (non-epicentre): a nationwide analysis of China | 12.1 | 279 | Citations (PDF) |
| 56 | A deep-learning-based prognostic nomogram integrating microscopic digital pathology and macroscopic magnetic resonance images in nasopharyngeal carcinoma: a multi-cohort study | 3.8 | 38 | Citations (PDF) |
| 57 | DDX24 Mutations Associated With Malformations of Major Vessels to the Viscera | 10.6 | 14 | Citations (PDF) |
| 58 | Versatile Octapod-Shaped Hollow Porous Manganese(II) Oxide Nanoplatform for Real-Time Visualization of Cargo Delivery | 8.7 | 74 | Citations (PDF) |
| 59 | ZnAs@SiO<sub>2</sub> nanoparticles as a potential anti-tumor drug for targeting stemness and epithelial-mesenchymal transition in hepatocellular carcinoma via SHP-1/JAK2/STAT3 signaling | 11.5 | 77 | Citations (PDF) |
| 60 | The relationship between autophagy and the immune system and its applications for tumor immunotherapy | 32.3 | 321 | Citations (PDF) |
| 61 | Generation of functional hepatocyte-like cells from human bone marrow mesenchymal stem cells by overexpression of transcription factor HNF4α and FOXA2 | 2.6 | 13 | Citations (PDF) |
| 62 | Crosstalk between autophagy and epithelial-mesenchymal transition and its application in cancer therapy | 32.3 | 269 | Citations (PDF) |
| 63 | MicroRNA hsa-miR-623 directly suppresses MMP1 and attenuates IL-8-induced metastasis in pancreatic cancer | 4.0 | 26 | Citations (PDF) |
| 64 | Angong Niuhuang Pill as adjuvant therapy for treating acute cerebral infarction and intracerebral hemorrhage: A meta-analysis of randomized controlled trials | 5.6 | 46 | Citations (PDF) |
| 65 | m6A-induced lncRNA RP11 triggers the dissemination of colorectal cancer cells via upregulation of Zeb1 | 32.3 | 338 | Citations (PDF) |
| 66 | Regional biomechanical imaging of liver cancer cells | 2.7 | 15 | Citations (PDF) |
| 67 | Inhibition of BRD4 suppresses the malignancy of breast cancer cells via regulation of Snail | 13.7 | 102 | Citations (PDF) |
| 68 | Characterizing viscoelastic properties of breast cancer tissue in a mouse model using indentation | 2.2 | 38 | Citations (PDF) |
| 69 | Accuracy of the diagnostic evaluation of hepatocellular carcinoma with LI-RADS | 1.3 | 34 | Citations (PDF) |
| 70 | Biodegradable Nanoagents with Short Biological Half‐Life for SPECT/PAI/MRI Multimodality Imaging and PTT Therapy of Tumors | 11.6 | 62 | Citations (PDF) |
| 71 | Biodegradable and Renal-Clearable Hollow Porous Iron Oxide Nanoboxes for in Vivo Imaging | 6.7 | 44 | Citations (PDF) |
| 72 | Preoperative radiomic signature based on multiparametric magnetic resonance imaging for noninvasive evaluation of biological characteristics in rectal cancer | 3.7 | 138 | Citations (PDF) |
| 73 | miR-30e acts as a tumor suppressor in hepatocellular carcinoma partly via JAK1/STAT3 pathway | 3.0 | 29 | Citations (PDF) |
| 74 | Intrahepatic biloma following transcatheter arterial chemoembolization for hepatocellular carcinoma: Incidence, imaging features and management | 1.3 | 15 | Citations (PDF) |
| 75 | Combination of EZH2 inhibitor and BET inhibitor for treatment of diffuse intrinsic pontine glioma | 5.6 | 53 | Citations (PDF) |
| 76 | Improved survival of patients with hepatocellular carcinoma and disparities by age, race, and socioeconomic status by decade, 1983-2012 | 1.7 | 51 | Citations (PDF) |
| 77 | Direct induction of hepatocyte-like cells from immortalized human bone marrow mesenchymal stem cells by overexpression of HNF4α | 2.1 | 22 | Citations (PDF) |
| 78 | Survival benefit of chemoembolization plus Iodine125 seed implantation in unresectable hepatitis B-related hepatocellular carcinoma with PVTT: a retrospective matched cohort study | 3.7 | 44 | Citations (PDF) |
| 79 | A facile route to core–shell nanoparticulate formation of arsenic trioxide for effective solid tumor treatment | 5.0 | 32 | Citations (PDF) |
| 80 | Safety and Efficacy of Transarterial Chemoembolization Combined with CT-Guided Radiofrequency Ablation for Hepatocellular Carcinoma Adjacent to the Hepatic Hilum within Milan Criteria | 1.1 | 5 | Citations (PDF) |
| 81 | In Vivo Bioluminescence Imaging of Transplanted Mesenchymal Stromal Cells and Their Rejection Mediated by Intrahepatic NK Cells | 2.2 | 15 | Citations (PDF) |
| 82 | Partial splenic embolization for thrombocytopenia in liver cirrhosis: predictive factors for platelet increment and risk factors for major complications | 3.7 | 36 | Citations (PDF) |
| 83 | Molecular Recognition of Human Liver Cancer Cells Using DNA Aptamers Generated via Cell-SELEX | 2.4 | 32 | Citations (PDF) |
| 84 | Polymeric vector-mediated gene transfection of MSCs for dual bioluminescent and MRI tracking in vivo | 12.3 | 46 | Citations (PDF) |
| 85 | Role of multi-detector computed tomography for biliary complications after liver transplantation | 4.8 | 7 | Citations (PDF) |
| 86 | Renal aspergillosis after liver transplantation: Clinical and imaging manifestations in two cases | 4.8 | 17 | Citations (PDF) |
| 87 | Study of the capability of multislice CT to diagnose arterioportal shunt in hepatocellular carcinoma | 0.0 | 0 | Citations (PDF) |
